Chad vs Macao: Previously treated cases tested for RR-/MDR-TB
Chad
95.0%
in 2024
Macao
96.0%
in 2024
Chad rank
66th
Macao rank
65th
Previously treated cases tested for RR-/MDR-TB over time
- Chad
- Macao
How they compare
Macao currently reports 96.0% against 95.0% in Chad, a difference of 1.0%.
The two have swapped places 4 times across 14 shared years of data; in 2010 it was Macao ahead.
Chad ranks 66th and Macao ranks 65th of 180 countries.
Across the 2 decades both report, Chad averaged higher in 1 and Macao in 1.
Head to head by decade
| Decade | Chad | Macao | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 21.5% | 84.6% | 63.0% | Macao |
| 2020s | 96.2% | 95.4% | 0.8% | Chad |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Chad or Macao?
- Macao, at 96.0% against 95.0% in Chad as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Chad and Macao?
- 1.0%, with Macao ahead.
- How many years of comparable data are there for Chad and Macao?
- 14 years are reported by both, from 2010 to 2024.
- How do Chad and Macao rank globally for previously treated cases tested for rr-/mdr-tb?
- Chad ranks 66th and Macao ranks 65th of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.